Bill S-214 explained in plain English
An Act to amend the Food and Drugs Act (cruelty-free cosmetics)
Federal Parliament bill summary, status, timeline, sponsor, votes, and official sources.
At a glance
Official Parliament of Canada snapshot for 42nd Parliament, 1st Session. MP vote breakdowns appear when the House of Commons publishes a recorded division export for that bill. Senate and House stage details include official debate/sitting links when LEGISinfo publishes them.
Our plain-language take, written for civic education.
Source: By PoliticalData.ca
Bill S-214 amends the Food and Drugs Act to ban cosmetic animal testing in Canada and prohibit the sale of cosmetics developed or manufactured using such testing.
Bill S-214, called the Cruelty-Free Cosmetics Act, makes changes to the Food and Drugs Act to stop animal testing for cosmetics in Canada. The bill prohibits anyone from conducting or causing cosmetic animal testing to happen in Canada. It also prevents the sale of cosmetics or cosmetic ingredients that were developed or manufactured using cosmetic animal testing done more than four years after the law comes into force. The bill also says that evidence from animal testing cannot be used to prove that a cosmetic is safe under federal law. However, the Minister of Health can authorize animal testing in specific situations where there is no other way to test for serious health problems linked to a cosmetic that is already widely used and cannot be easily replaced. Before the Minister grants such authorization, they must consult with the public. The Governor in Council can also make regulations to treat certain drugs as cosmetics under these new rules.
- Adds definitions of 'animal testing' and 'cosmetic animal testing' to the Food and Drugs Act
- Prohibits any person from conducting or causing cosmetic animal testing to be conducted in Canada
- Prohibits the sale of cosmetics developed or manufactured using cosmetic animal testing conducted more than four years after the law comes into force
- Prohibits the submission or use of evidence from animal testing to establish the safety of a cosmetic or cosmetic ingredient under federal law and regulations
- Allows the Minister to authorize cosmetic animal testing in limited circumstances when no alternative method exists to evaluate serious human health problems for a widely-used cosmetic that cannot be replaced
- Requires the Minister to conduct public consultations before authorizing cosmetic animal testing
- Allows the Governor in Council to designate drugs to be treated as cosmetics under these provisions
- Manufacturers and distributors of cosmetics in Canada
- Persons or organizations that conduct animal testing for cosmetic purposes in Canada
- Importers of cosmetics
- Health care regulators and the Minister of Health (regarding authorization and consultation duties)
- Animals used in cosmetic testing (non-human vertebrates)
- Consumers who purchase cosmetics
- Manufacturers must not develop or manufacture cosmetics using animal testing conducted more than four years after the law comes into force
- No person may conduct or cause cosmetic animal testing in Canada (Section 16.1)
- Regulators cannot accept animal testing evidence from more than four years after the law comes into force to prove cosmetic safety
- The Minister must conduct public consultations before authorizing any exemption for cosmetic animal testing (Section 18.2(2))
- The Minister may authorize limited animal testing only when no alternative method exists and specific conditions are met (Section 18.2(1))
- A four-year transition period applies after the law comes into force: cosmetics developed or manufactured using animal testing conducted within four years after commencement are permitted, but those tested after that four-year window are prohibited
- The bill text does not specify what penalties or enforcement mechanisms apply to violations
- The bill does not specify the exact commencement date of the law; it references 'the day on which this paragraph/section comes into force'
- The bill does not define what specific 'prescribed form and manner' the Minister must follow for authorizations or public consultations
- The bill does not detail what constitutes 'substantiated specific human health problems' or how the Minister determines if a cosmetic cannot be replaced
- The bill does not specify what regulations the Governor in Council may make regarding drugs treated as cosmetics
- The bill does not clarify whether products already in circulation or approved before the law comes into force will be grandfathered
New definitions are added for 'animal testing' (application or administration of any substance to a live non-human vertebrate to evaluate safety or efficacy) and 'cosmetic animal testing' (application or administration of a cosmetic or its ingredient to a live non-human vertebrate to evaluate safety or efficacy for developing or manufacturing a cosmetic)
Source: Section 2
A new ground is added to prohibit the sale of cosmetics that were developed or manufactured using cosmetic animal testing conducted more than four years after the law comes into force
Source: Section 16, paragraph (d)
A new prohibition is established: no person may conduct or cause cosmetic animal testing to be conducted in Canada
Source: Section 16.1
Evidence from animal testing conducted more than four years after the law comes into force cannot be submitted or used to prove a cosmetic is safe
Source: Section 18.1
The Minister can authorize cosmetic animal testing if there is no alternative method to test for serious human health problems linked to a widely-used cosmetic that cannot be replaced, and must conduct public consultations first
Source: Section 18.2
The Governor in Council can make regulations to designate drugs that should be treated as cosmetics under these cruelty-free provisions
Source: Section 18.3
Generated using AI from official bill text. Not legal advice. It is written by PoliticalData.ca for civic education, automatically checked and spot-reviewed before publishing.
Official textParliamentary Process
Bill S-214, concerning cruelty-free cosmetics, completed its first reading in the Senate on December 10, 2015, and has since advanced through various stages in both the Senate and the House of Commons, currently being at the second reading stage in the House of Commons.
This artifact describes the procedural steps for Bill S-214, An Act to amend the Food and Drugs Act (cruelty-free cosmetics), in the Senate. The bill completed its first reading on December 10, 2015. It later moved through second reading, committee consideration, report stage, and third reading in the Senate before being sent to the House of Commons. The bill is currently at the second reading stage in the House of Commons.
Bill S-214, concerning cruelty-free cosmetics, was introduced and received first reading in the Senate on December 10, 2015, as a procedural step.
On December 10, 2015, Bill S-214, an Act to amend the Food and Drugs Act (cruelty-free cosmetics), was introduced in the Senate and received its first reading. This is a procedural step and does not involve debate on the bill's content at this stage. The artifact provided primarily consists of records of Senators' Statements on various topics and debates on other Senate business, including the Speech from the Throne and committee reports, but it does not contain the text of the debate specifically on Bill S-214's first reading.
Bill S-214, concerning cruelty-free cosmetics, completed its second reading stage in the Senate, involving sponsor and response speeches, before moving to the House of Commons.
This artifact describes the progress of Bill S-214, An Act to amend the Food and Drugs Act (cruelty-free cosmetics), specifically its second reading stage in the Senate. This stage involved speeches from senators. The bill was later considered in the House of Commons and has advanced through several stages there as well. The provided text does not contain the full bill or details about specific amendments.
During a Senate sitting on February 3, 2016, Bill S-214, aimed at ending animal testing for cosmetics in Canada, was debated at second reading, alongside other Senate business and a Question Period with the Minister of Fisheries, Oceans and the Canadian Coast Guard.
This Senate sitting on February 3, 2016, included a debate on Bill S-214, an Act to amend the Food and Drugs Act concerning cruelty-free cosmetics. Senator Carolyn Stewart Olsen moved second reading of the bill, explaining its intent to prohibit animal testing for cosmetics and the sale of cosmetics tested on animals in Canada. She detailed how the bill would amend the Food and Drugs Act and introduced provisions for the Health Minister to authorize animal testing in rare cases where no alternatives exist, with a requirement for public consultation. The debate also touched upon the evolution of scientific testing methods and international trends towards banning animal-tested cosmetics. The sitting also included tributes, tabling of committee reports, introduction of a Criminal Code amendment bill, and discussions on other legislative matters. The Question Period featured the Minister of Fisheries, Oceans and the Canadian Coast Guard addressing issues such as marine conservation, shipbuilding, aquaculture, salmon stocks, and international fish harvesting.
During a Senate debate on February 3, 2016, the sponsor of Bill S-214, an Act to amend the Food and Drugs Act (cruelty-free cosmetics), explained its intent to prohibit animal testing for cosmetics in Canada and the sale of products tested on animals, while acknowledging advancements in alternative testing methods and a provision for rare exceptions.
This document records a debate in the Senate on February 3, 2016, regarding Bill S-214, an Act to amend the Food and Drugs Act concerning cruelty-free cosmetics. The sponsor of the bill, Senator Carolyn Stewart Olsen, delivered a speech outlining the bill's purpose: to end animal testing for cosmetics in Canada and the sale of cosmetics tested on animals. She explained that the bill would amend the Food and Drugs Act to prohibit animal testing and the use of evidence from such testing for cosmetic safety. The speech also highlighted advancements in alternative testing methods and addressed potential concerns from the cosmetics industry by including a provision for the Health Minister to authorize animal testing only when no alternatives exist and human health concerns are substantiated. The debate also touched upon the broader issue of animal welfare legislation in Canada and internationally, noting that other countries have already implemented bans on animal-tested cosmetics. The speech concluded by framing the bill as a necessary step towards modernizing Canada and becoming a leader in cruelty-free practices. Following the speech, the debate was adjourned. The record also includes various other proceedings of the Senate on that day, such as tributes, tabling of reports, introduction of other bills, notices of motions, and Question Period with the Minister of Fisheries, Oceans and the Canadian Coast Guard.
On February 4, 2016, the Senate held a sitting that included tributes, discussions on various motions and committee business, and continued debate on Bill S-214 concerning cruelty-free cosmetics.
This record details a sitting of the Senate on February 4, 2016. The sitting included tributes to Alberta "Bertie" Hensel Pew Baker, discussions about a tuition fund for families of fallen public safety officers, and greetings for the Lunar New Year. Procedural matters were addressed, including tabling of reports, notices of motions regarding committee studies and Question Period, and debates on several bills. Notably, debate on Bill S-214, concerning cruelty-free cosmetics, continued at second reading. Other proceedings involved discussions on the role of ministers in Senate Question Period, the process for appointing a Speaker, and committee business. The sitting concluded with an adjournment motion.
On April 20, 2016, the Senate convened, delivering tributes, tabling reports, and continuing debate on various matters, including adjourning the debate on Bill S-214 concerning cruelty-free cosmetics.
This document records a Senate sitting on April 20, 2016. The Senate dealt with various matters including tributes to Bernard Lamarre, congratulations to Senator Serge Joyal, discussions on the Chernobyl disaster, and the results of the Manitoba provincial election. The Senate also addressed the Journey to Freedom Day, tabled several committee reports, and continued debate on the Speech from the Throne and the "Canadian Public Corporations Governance Bill" (Bill S-216). Additionally, a motion was passed to authorize the Standing Senate Committee on Legal and Constitutional Affairs to study the subject matter of Bill C-14 (medical assistance in dying) in advance. The sitting also included a procedural discussion about Question Period timing and the continuation of debate on Bill S-214, "An Act to amend the Food and Drugs Act (cruelty-free cosmetics)", which was adjourned.
During a Senate sitting on May 4, 2016, the debate on Bill S-214 (cruelty-free cosmetics) continued, with a senator expressing support but raising concerns about human safety, alongside discussions on other pressing national and international issues.
This Senate sitting on May 4, 2016, included a debate on Bill S-214, An Act to amend the Food and Drugs Act (cruelty-free cosmetics). Senator Lillian Eva Dyck spoke on the bill, generally supporting it but raising concerns about human safety and the potential impact of banning all animal testing. The sitting also included discussions on the wildfires in Fort McMurray, Mental Health Week, Bladder Cancer Awareness Month, and various foreign affairs and domestic policy matters. A point of order regarding Senate rules and titles was also debated. Finally, there was a debate on Bill S-210, which sought to amend the short title of an act related to barbaric cultural practices.
During a Senate debate on Bill S-214 (cruelty-free cosmetics), a key speaker expressed support for banning animal testing but raised critical questions about ensuring human safety and the scope of the proposed ban.
This record details a Senate debate on Bill S-214, "An Act to amend the Food and Drugs Act (cruelty-free cosmetics)." Senator Lillian Eva Dyck spoke as the critic, indicating general support for the bill's aim to ban animal testing in the development and manufacturing of cosmetics. However, she raised significant concerns regarding the safety of cosmetic products for human users, questioning whether the bill adequately addresses this aspect. She also explored the definition of 'cruelty-free,' the potential impact of banning data derived from past animal testing, and the minister's power to make exceptions. The debate also touched upon the effectiveness of the proposed ban given the current low level of animal testing in Canada and the potential for international implications. Other discussions in the Senate on this date included statements on the Fort McMurray wildfires, Mental Health Week, Bladder Cancer Awareness Month, a notice of motion regarding Question Period, the first reading of another bill, and reports tabled. There was also a point of order raised and debated concerning the titles and duties of Senate leadership roles.
During a Senate sitting on September 28, 2016, various procedural matters were addressed, and the debate on Bill S-214, concerning cruelty-free cosmetics, was adjourned.
This Senate sitting on September 28, 2016, included various proceedings. While the official transcript lists Bill S-214, "An Act to amend the Food and Drugs Act (cruelty-free cosmetics)" under 'ORDERS OF THE DAY' for 'Second Reading—Debate Continued', the provided text does not contain the debate itself. Instead, it details other Senate business, including statements by senators on various topics, routine proceedings, question period addressing multiple government and policy issues, and other legislative items at different stages. The debate on Bill S-214 was adjourned by Senator Yonah Martin.
The Senate sat on November 15, 2016, to introduce new senators, hear statements, conduct routine proceedings, engage in question period on various government matters, and continue debate on several bills, including Bill S-214.
This document is a record of a Senate sitting on November 15, 2016. The sitting included the introduction of new senators, statements on various topics including the late Leonard Cohen and the restoration of a resort, routine proceedings where committee reports were tabled and authorized to meet, and the continuation of debate on several bills. Question Period also took place, featuring discussions on labour unions, pension plans, the temporary foreign worker program, and the aerospace industry. The sitting concluded with the adjournment of several debates and the Senate rising for the day.
On December 13, 2016, the Senate held a sitting that included tributes to a retiring senator, question period on various issues, and debate and committee referrals for several bills, notably Bill S-214 on cruelty-free cosmetics.
On December 13, 2016, the Senate convened. The sitting included tributes to Senator Wilfred P. Moore, who was retiring. Routine proceedings covered committee reports and notices of motions. Question Period addressed softwood lumber negotiations, the Trudeau Foundation, RCMP collective bargaining, Canada-U.S. trade, victims' rights, and crude oil tanker moratoria. The Senate then proceeded with debate and votes on several bills, including amendments to the Canada Pension Plan, Budget Implementation Bill, Tobacco Act, Non-smokers' Health Act, Criminal Code, and the Food and Drugs Act concerning cruelty-free cosmetics. Several committee reports were presented and adopted, and various inquiries and debates were adjourned or continued. Bill S-214, concerning cruelty-free cosmetics, was read a second time and referred to committee.
Bill S-214, aiming to amend the Food and Drugs Act regarding cruelty-free cosmetics, completed its committee stage review in the Senate on October 5, 2017.
This record indicates that Bill S-214, concerning cruelty-free cosmetics, completed its 'Consideration in committee' stage in the Senate on October 5, 2017. This stage involves a detailed review of the bill by a committee of senators. The bill has since moved on to other stages in both the Senate and the House of Commons.
The Senate received a committee report with amendments on Bill S-214 concerning cruelty-free cosmetics.
On October 5, 2017, the Senate was in session. During Routine Proceedings, the Standing Senate Committee on Social Affairs, Science and Technology presented its Sixteenth Report on Bill S-214, An Act to amend the Food and Drugs Act (cruelty-free cosmetics). The committee reported the bill with amendments. The report was then placed on the Orders of the Day for consideration at the next sitting. Other proceedings included tributes to former senators, tabling of reports, notices of motions, and debates on various bills and issues, including the Energy East pipeline, advance directives, the national Holocaust memorial, the icebreaker fleet, the Phoenix pay system, and the Rohingya crisis in Myanmar.
Bill S-214, which aims to amend the Food and Drugs Act regarding cruelty-free cosmetics, has completed its report stage in the Senate and is now at the second reading stage in the House of Commons.
The Senate Report stage for Bill S-214, concerning cruelty-free cosmetics, was completed on February 15, 2018. The bill has since moved to the House of Commons and is currently at the second reading stage.
During a Senate sitting on October 17, 2017, debate on Bill S-214 (cruelty-free cosmetics) was adjourned after considering committee amendments, while other Senate business including tabling of reports, questions to the Minister of Natural Resources, and debates on various social and foreign policy issues also took place.
On October 17, 2017, the Senate convened for a sitting that included routine proceedings, question period, and orders of the day. During the sitting, several items were tabled, including committee reports and responses to written questions. Notably, debate on Bill S-214, an Act to amend the Food and Drugs Act (cruelty-free cosmetics), was adjourned after consideration of the sixteenth report of the Standing Senate Committee on Social Affairs, Science and Technology. The committee had agreed to two amendments, including extending the bill's implementation period by four years after Royal Assent. Other items discussed included amendments to other bills, motions regarding committee studies, and debates on various inquiries and motions concerning issues like human rights, Indigenous women in the justice system, autism, and literacy programs. The sitting also featured Question Period where the Minister of Natural Resources responded to questions on energy infrastructure, pipelines, and climate change adaptation.
This Senate sitting on December 5, 2017, featured tributes, committee business, and ongoing debates and considerations of multiple bills, including those related to budget implementation, transportation, criminal code amendments, palliative care, and cruelty-free cosmetics.
This record details a Senate sitting on December 5, 2017. The sitting included tributes to the 100th anniversary of the Halifax Explosion, discussions on children's rights, and the presentation of various committee reports and notices of motions. The Senate also debated and advanced several bills, including the Budget Implementation Bill, 2017, No. 2 (Bill C-63), the Miscellaneous Statute Law Amendment Bill, 2017 (Bill C-60), the Criminal Code amendment bill (Bill C-46), and the Canada Transportation Act amendment bill (Bill C-49). The sitting also included Question Period where the Minister of Families, Children and Social Development addressed various questions. Finally, debate continued on Bill S-219 (Non-Nuclear Sanctions Against Iran Bill) and Bill C-277 (Framework on Palliative Care in Canada Bill), and the Senate considered a report on Bill S-214 concerning cruelty-free cosmetics. The sitting concluded with discussions on policies for responding to harassment complaints against senators and the study of regulatory issues related to connected and automated vehicles.
The Senate adopted the report of the Social Affairs, Science and Technology Committee on Bill S-214, which amends the Food and Drugs Act regarding cruelty-free cosmetics, and scheduled the bill for third reading.
On February 15, 2018, the Senate was in session. During this sitting, the Senate adopted the sixteenth report of the Standing Senate Committee on Social Affairs, Science and Technology concerning Bill S-214, an Act to amend the Food and Drugs Act (cruelty-free cosmetics). Following the adoption of the committee's report, the bill was placed on the Orders of the Day for third reading at the next sitting.
Bill S-214, aimed at amending the Food and Drugs Act to address cruelty-free cosmetics, completed its third reading in the Senate on June 19, 2018, and was subsequently at second reading in the House of Commons.
The provided text outlines the legislative journey of Bill S-214, an Act to amend the Food and Drugs Act concerning cruelty-free cosmetics. The artifact specifically details the bill's progression through the Senate, including its third reading, which was completed on June 19, 2018. It also notes the bill's subsequent stages in the House of Commons, where it was at second reading as of the information's last update. The text lists key dates for readings, committee considerations, and report stages in both chambers, as well as major speeches given. It also references a similar bill, S-234, from a previous parliamentary session.
During a Senate sitting on March 1, 2018, the third reading debate of Bill S-214, an act to amend the Food and Drugs Act concerning cruelty-free cosmetics, was adjourned.
This artifact is a record of a Senate sitting on March 1, 2018, during which the Senate debated Bill S-214, An Act to amend the Food and Drugs Act (cruelty-free cosmetics). While the sitting included various procedural matters, discussions on other bills, and tributes, the key procedural event related to Bill S-214 was its third reading debate. The debate was ultimately adjourned.
On May 22, 2018, the Senate held a sitting that included Senator statements, routine proceedings, debate on Bill S-214 at third reading, Question Period with a Minister, and debates on Bill S-245 and other inquiries and bills.
This is a record of a Senate sitting that took place on May 22, 2018. The Senate spent time on various matters including statements from Senators on current events, routine proceedings such as presenting committee reports and reading bills for the first time, and debate on specific bills at the third reading stage. The sitting also included a question period with the Minister of Employment, Workforce Development and Labour, and continued debate on other bills and inquiries. The sitting concluded with the Senate adjourning to the next day.
On June 19, 2018, the Senate completed its third reading and passed Bill S-214, "An Act to amend the Food and Drugs Act (cruelty-free cosmetics)," "on division," following extensive debates and votes on other legislative matters.
This document is a record of a Senate sitting on June 19, 2018. While the bill "An Act to amend the Food and Drugs Act (cruelty-free cosmetics)" (Bill S-214) is listed under "Orders of the Day" as being at "Third Reading," the provided text does not contain the debate or any procedural actions related to this specific bill. Instead, the sitting record details other Senate business, including statements by senators, routine proceedings, question period, and extensive debates on other bills (Bill C-80, Bill C-45, Bill S-203, and Bill S-237) and committee reports (Bill C-74). The sitting concluded with a vote on Bill S-214, which was passed "on division."
This record outlines the procedural history of Bill S-214 in the House of Commons, including its first reading on April 12, 2019, and its current status at second reading.
This artifact details the procedural steps for Bill S-214 in the House of Commons. The bill's first reading in the House of Commons occurred on April 12, 2019. The provided text also lists subsequent procedural stages and dates for this bill, as well as information about similar bills and speeches given in both the Senate and the House of Commons. It notes that the bill is currently at second reading in the House of Commons.
On April 12, 2019, in the House of Commons, Bill S-214, an Act to amend the Food and Drugs Act (cruelty-free cosmetics), successfully completed its first reading.
This artifact is a record of the House of Commons sitting on April 12, 2019. The primary procedural event related to Bill S-214 was its First Reading. Specifically, Ms. Marilyn Gladu (Sarnia—Lambton, CPC) moved that Bill S-214, "An Act to amend the Food and Drugs Act (cruelty-free cosmetics)", be read the first time. This motion was agreed to, and the bill was read the first time. The record also includes various debates on other matters, including the Budget Implementation Act, 2019, No. 1 (Bill C-97), points of order, and statements by members on a range of topics. The act to amend the Food and Drugs Act (cruelty-free cosmetics) was introduced and read for the first time.
Bill S-214, concerning cruelty-free cosmetics, was at the second reading stage in the House of Commons, with a debate occurring on June 3, 2019, but this stage was not completed.
This artifact describes the House of Commons Second Reading stage for Bill S-214, "An Act to amend the Food and Drugs Act (cruelty-free cosmetics)". The process shows that the bill had its second reading debate on Monday, June 3, 2019, and this stage was not completed. The artifact also lists previous and subsequent stages of the bill's progress, including its first reading in the House of Commons on Thursday, December 10, 2015, and various committee, report, and third reading stages. It also notes that a similar bill, S-234, was introduced in a previous Parliament.
During the House of Commons second reading debate on Bill S-214, Members discussed proposed amendments to ban cosmetic animal testing and the sale of animal-tested cosmetics, with considerations for clarity, responsibility, and potential impacts on various sectors.
On June 3, 2019, Members of the House of Commons debated Bill S-214, an Act to amend the Food and Drugs Act (cruelty-free cosmetics). The debate focused on the bill's intent to ban cosmetic animal testing and the sale of cosmetics tested on animals. Several amendments were proposed to clarify the bill's scope, such as ensuring the ban does not apply to pet grooming products or substances regulated as food or drugs, and to designate manufacturers or importers as the responsible parties for compliance. Concerns were raised about the bill's potential impact on jobs and the timeline for its passage, with indications that it might not be passed in the current parliamentary session.
During the second reading debate on Bill S-214, the sponsor outlined the bill's purpose to ban cosmetic animal testing and explained proposed amendments, while other members discussed the legislation's implications and public support.
On June 3, 2019, the House of Commons began its second reading debate on Bill S-214, An Act to amend the Food and Drugs Act (cruelty-free cosmetics). The sponsor of the bill, Ms. Marilyn Gladu, delivered her speech, explaining the bill's intent to ban cosmetic animal testing and the sale of cosmetics tested on animals in Canada. She outlined several proposed amendments to clarify the bill's scope, including specifying that the ban would not apply to pet grooming products and would hold manufacturers and importers responsible for compliance. She also mentioned that the bill would not apply to animal testing conducted for regulatory purposes of food, drugs, or natural health products, and that exemptions could be granted by the Minister of Health in cases of serious health risks. Other members participated in the debate, discussing the bill's potential impact, the progress of similar legislation in other countries, and the importance of public support for the initiative.
During the second reading debate in the House of Commons on Bill S-214, members discussed proposed amendments to ban animal testing for cosmetics and the sale of such products in Canada.
This document records a debate in the House of Commons on Bill S-214, concerning cruelty-free cosmetics. The debate involved members from different parties discussing the bill's progress, proposed amendments, and the broader implications of banning animal testing for cosmetic products. Several speakers noted the bill's origin in the Senate and its unanimous passage there, but also highlighted disagreements and the need for amendments before it could proceed further in the House of Commons.
A Member of Parliament debated Bill S-214, an act to amend the Food and Drugs Act to ban cosmetic animal testing and the sale of cosmetics tested on animals, outlining proposed amendments and international comparisons while acknowledging concerns about implementation and timeline.
During a House of Commons debate on Bill S-214, the Act to amend the Food and Drugs Act (cruelty-free cosmetics), a Member of Parliament spoke about the bill's intent to ban cosmetic animal testing and the sale of cosmetics tested on animals. The Member explained proposed amendments to clarify that the ban would not apply to products for non-human use, would hold manufacturers and importers responsible, would not apply to testing for food or drugs, and would allow for ministerial exemptions in cases of serious health risks. The Member also noted that the bill originated in the Senate, passed unanimously there, and aimed to align Canada with international practices. Concerns were raised about the bill's potential impact on jobs and the timeline for its passage.
Bill S-214, an Act to amend the Food and Drugs Act (cruelty-free cosmetics), has not yet reached the committee stage in the House of Commons and is currently at the second reading stage.
This artifact indicates that Bill S-214, concerning cruelty-free cosmetics, has not yet reached the stage of "Consideration in committee" in the House of Commons. The bill's current status is "At second reading in the House of Commons". The last activity noted was debate at second reading on Monday, June 3, 2019.
The House of Commons has not yet reached the Report stage for Bill S-214, which aims to amend the Food and Drugs Act concerning cruelty-free cosmetics.
The House of Commons has not yet reached the Report stage for Bill S-214. The artifact indicates that this stage is 'Not reached'. The bill has progressed through first and second readings, consideration in committee, and third reading in the House of Commons. It then moved to the Senate for first reading and second reading.
Bill S-214 has not yet reached the third reading stage in the House of Commons and is currently at second reading, with a record of its progression through earlier parliamentary stages and mentions of related bills.
The artifact indicates that Bill S-214 has not yet reached the 'House of Commons Third reading' stage. The bill's current status is 'At second reading in the House of Commons', with the latest activity being debate at second reading on June 3, 2019. The provided text outlines the bill's progression through various stages in both the Senate and the House of Commons, including first reading, second reading, consideration in committee, report stage, and third reading, with specific dates and sitting numbers noted for some of these events. It also mentions similar bills introduced in a previous Parliament.
Debate and sitting links point to official parliamentary sources when LEGISinfo publishes them. Any plain-language discussion summaries should be generated from those official texts and reviewed before public display.
Vote Summary
This bill is still active. We only show vote counts after the legislature publishes a recorded division.
No published representative vote breakdown
This bill is still moving through the process. When a recorded division is published, representative positions can be listed here.
Official sources
Status, sponsor, votes, and timeline on this page are drawn from these official legislative sources and public records. Each summary above is attributed to its own source.
How this data is sourced